2018
DOI: 10.4103/ctm.ctm_6_18
|View full text |Cite
|
Sign up to set email alerts
|

The role of reactive oxygen species in screening anticancer agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Several anticancer drugs act by inhibiting and suppressing cancer progression through ROS-mediated cell death [63]. ROS are highly reactive and extremely unstable molecules.…”
Section: Production Of Rosmentioning
confidence: 99%
“…Several anticancer drugs act by inhibiting and suppressing cancer progression through ROS-mediated cell death [63]. ROS are highly reactive and extremely unstable molecules.…”
Section: Production Of Rosmentioning
confidence: 99%
“…ROS is regarded as the target of the anticancer agents in cancer therapy. Prooxidants as anticancer agents induce apoptosis in cancer cells through promoting ROS signalling pathways and weakening the antioxidant defence system of cancer cells [35]. Flavonoids display prooxidant activity modulating cell signalling which is thought to be directly proportional to the total number of hydroxyl groups [36].…”
Section: Introductionmentioning
confidence: 99%